1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. Y-MABS THERAPEUTICS INC
Y-Mabs Therapeutics Inc XNAS: YMAB

Y-Mabs Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...

Read More
8.55 0.01 (0.12%)
46.89% Fall from 52W High
398.3K
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
14.7 / 100
Momentum Score
Technically Neutral
58.3 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
9
1Yr Price target upside is 1%
7 analysts

20

S

6

W

0

O

3

T

SWOT Analysis

Y-Mabs Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..